rofecoxib has been researched along with Coronary Disease in 7 studies
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the influence of low dose rofecoxib on inflammatory mediators and prostacyclin synthesis in patients with acute coronary syndromes (ACS) in a short-term follow up." | 9.11 | Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes. ( Dobrzycki, S; Kamiński, KA; Kralisz, P; Kuklińska, AM; Modrzejewski, W; Musiał, WJ; Sobkowicz, B; Stec, S; Wojtkowska, I, 2005) |
| "To assess the influence of low dose rofecoxib on inflammatory mediators and prostacyclin synthesis in patients with acute coronary syndromes (ACS) in a short-term follow up." | 5.11 | Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes. ( Dobrzycki, S; Kamiński, KA; Kralisz, P; Kuklińska, AM; Modrzejewski, W; Musiał, WJ; Sobkowicz, B; Stec, S; Wojtkowska, I, 2005) |
| "Among 7." | 1.33 | Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization? ( Coupal, L; Grover, SA; Zowall, H, 2005) |
| "Naproxen was associated with an OR of 0." | 1.32 | Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population. ( García Rodríguez, LA; González-Pérez, A; Maguire, A; Varas-Lorenzo, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ray, WA | 1 |
| Stein, CM | 1 |
| Daugherty, JR | 1 |
| Hall, K | 1 |
| Arbogast, PG | 1 |
| Griffin, MR | 1 |
| Monakier, D | 1 |
| Mates, M | 1 |
| Klutstein, MW | 1 |
| Balkin, JA | 1 |
| Rudensky, B | 1 |
| Meerkin, D | 1 |
| Tzivoni, D | 1 |
| García Rodríguez, LA | 1 |
| Varas-Lorenzo, C | 1 |
| Maguire, A | 1 |
| González-Pérez, A | 1 |
| Grover, SA | 1 |
| Coupal, L | 1 |
| Zowall, H | 1 |
| Kuklińska, AM | 1 |
| Musiał, WJ | 1 |
| Kamiński, KA | 1 |
| Kralisz, P | 1 |
| Modrzejewski, W | 1 |
| Sobkowicz, B | 1 |
| Dobrzycki, S | 1 |
| Stec, S | 1 |
| Wojtkowska, I | 1 |
| Valat, JP | 1 |
| Deray, G | 1 |
| Héloire, F | 1 |
1 review available for rofecoxib and Coronary Disease
| Article | Year |
|---|---|
[Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cerebrovascular Disorders; Coronar | 2006 |
2 trials available for rofecoxib and Coronary Disease
| Article | Year |
|---|---|
Rofecoxib, a COX-2 inhibitor, lowers C-reactive protein and interleukin-6 levels in patients with acute coronary syndromes.
Topics: Acute Disease; Angina, Unstable; C-Reactive Protein; Coronary Disease; Cyclooxygenase Inhibitors; Do | 2004 |
Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antichol | 2005 |
4 other studies available for rofecoxib and Coronary Disease
| Article | Year |
|---|---|
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Coronary Disease; Cyclo | 2002 |
Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiotonic Agents; Case- | 2004 |
Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Blood Pressure; Celecoxib; C | 2005 |
Top 10 health stories of 2004.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antidepressive Agents; Antineopla | 2004 |